Stay updated on Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.9.7 to 2.10.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-07-23T14:40:15.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T07:47:18.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The change in the web page value represents an update to the DOI (Digital Object Identifier) for the article 'Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040)' published in Lancet. The updated DOI is now 10.1016/S0140-6736(18)33261-6.
    Difference
    0.0%
    Check dated 2024-07-03T14:36:47.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-07-02T14:19:14.000Z thumbnail image
  9. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content version.
    Difference
    0.0%
    Check dated 2024-06-27T10:15:37.000Z thumbnail image
  10. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-26T09:04:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.